Blood Vessel Maturation by Disintegrin in Oxygen-Induced Retinopathy.

about

Blood Vessel Maturation by Disintegrin in Oxygen-Induced Retinopathy.

Item

http://www.wikidata.org/entity/Q53413992

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Blood Vessel Maturation by Disintegrin in Oxygen-Induced Retinopathy.

@en

Blood Vessel Maturation by Disintegrin in Oxygen-Induced Retinopathy.

@nl

type

Item

label

Blood Vessel Maturation by Disintegrin in Oxygen-Induced Retinopathy.

@en

Blood Vessel Maturation by Disintegrin in Oxygen-Induced Retinopathy.

@nl

prefLabel

Blood Vessel Maturation by Disintegrin in Oxygen-Induced Retinopathy.

@en

Blood Vessel Maturation by Disintegrin in Oxygen-Induced Retinopathy.

@nl

P1476

Blood Vessel Maturation by Disintegrin in Oxygen-Induced Retinopathy.

@en

P2093

Doo-Sik Kim

http://www.w3.org/2001/XMLSchema#string

Hyun Jong Kim

http://www.w3.org/2001/XMLSchema#string

Jin-Wook Jang

http://www.w3.org/2001/XMLSchema#string

Jong Min Kim

http://www.w3.org/2001/XMLSchema#string

Oh Woong Kwon

http://www.w3.org/2001/XMLSchema#string

Sung Jin Lee

http://www.w3.org/2001/XMLSchema#string

Yang Je Cho

http://www.w3.org/2001/XMLSchema#string

P2860

The role of pericytes in blood-vessel formation and maintenance

Applications of snake venom components to modulate integrin activities in cell-matrix interactions

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

Vascular-specific growth factors and blood vessel formation

Structural basis of integrin regulation and signaling

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

Endothelial/pericyte interactions

Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration.

A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.

Endothelial-pericyte interactions in angiogenesis.

P304

689-699

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/02713683.2015.1050737

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26200105

http://www.w3.org/2001/XMLSchema#string